Oncolytics Biotech (TSE:ONC) Shares Pass Above Two Hundred Day Moving Average of $2.51

Oncolytics Biotech Inc. (TSE:ONCGet Free Report)’s share price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of C$2.51 and traded as high as C$3.01. Oncolytics Biotech shares last traded at C$2.94, with a volume of 115,676 shares changing hands.

Analysts Set New Price Targets

Separately, Jonestrading set a C$9.00 price target on shares of Oncolytics Biotech and gave the stock a “buy” rating in a report on Wednesday, May 24th.

Check Out Our Latest Stock Analysis on Oncolytics Biotech

Oncolytics Biotech Stock Up 2.8 %

The company has a market cap of C$212.77 million, a PE ratio of -6.26 and a beta of 1.75. The business has a 50-day simple moving average of C$3.39 and a 200-day simple moving average of C$2.51. The company has a quick ratio of 8.86, a current ratio of 11.69 and a debt-to-equity ratio of 2.15.

About Oncolytics Biotech

(Get Free Report)

Oncolytics Biotech Inc, a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.

Featured Stories

Receive News & Ratings for Oncolytics Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncolytics Biotech and related companies with MarketBeat.com's FREE daily email newsletter.